Development and validation of a deep learning framework for Alzheimer’s disease classification
Vijaya B. Kolachalama(Boston University), Rhoda Au(Boston University), E. Alton Sartor(Boston University), Prajakta Joshi(Boston University), Michelle Kaku(Icahn School of Medicine at Mount Sinai), Gary H. Chang(Boston University), Yazan J. Alderazi(Texas Tech University), Marie Saint‐Hilaire(Boston University), Jing Yuan(Shandong Provincial QianFoShan Hospital), Shangran Qiu(Boston University), Cody Karjadi(Boston University), Sachin Kedar(University of Nebraska Medical Center), Arun Swaminathan(University of Pittsburgh), Shuhan Zhu(Boston University), Brigid Dwyer(Boston University), Chonghua Xue(Boston University), Yan Zhou(University of Electronic Science and Technology of China), Anant S. Joshi(Georgia Institute of Technology), Matthew I. Miller(Boston University), Sanford Auerbach(Boston University)
Cited by 0
Related Papers
Clinical Pharmacokinetics of Tacrolimus
|Clinical Pharmacokinetics|1995|802
Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players
|Journal of Neurotrauma|2016|565
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
|Brain|2020|487
Multimodal deep learning for Alzheimer’s disease dementia assessment
|Nature Communications|2022|390